Experienced in Myelofibrosis

Bin Q. Wu

No. 135, Xingang Xi Road, 
Guangzhou, CN 
Experienced in Myelofibrosis
No. 135, Xingang Xi Road, 
Guangzhou, CN 
OverviewLocationsClinical Research

Overview

Bin Wu practices in Guangzhou, China. Mr. Wu is rated as an Experienced expert by MediFind in the treatment of Myelofibrosis. His top areas of expertise are Portal Hypertension, Cirrhosis, Brain Abscess, Deep Brain Stimulation, and Ileostomy.

His clinical research consists of co-authoring 279 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Myelofibrosis.

Gender
Male

Locations

No. 135, Xingang Xi Road, Guangzhou, 510275, China
Other Locations
No. 600 Tianhe Road, Guangzhou, 510630, China
69 Yongding Road, Haidian, 100039, China
600 Tianhe Road, Guangzhou, 510630, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Investigation of the Clinical, Radiological and Biological Factors Associated With Disease Progression, Phenotypes and Endotypes of COPD in China
Investigation of the Clinical, Radiological and Biological Factors Associated With Disease Progression, Phenotypes and Endotypes of COPD in China
Enrollment Status: Completed
Publish Date: August 20, 2025
Intervention Type: Other
A Phase III, 12 Week, Randomized, Double-blind, 4 Arm Parallel Group Bridging Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination FF/UMEC/VI Once-daily Via a Dry Powder Inhaler With Dual Combination of FF/VI, Administered in Chinese Participants With Inadequately Controlled Asthma
A Phase III, 12 Week, Randomized, Double-blind, 4 Arm Parallel Group Bridging Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination FF/UMEC/VI Once-daily Via a Dry Powder Inhaler With Dual Combination of FF/VI, Administered in Chinese Participants With Inadequately Controlled Asthma
Enrollment Status: Completed
Publish Date: August 11, 2025
Intervention Type: Device, Drug
Study Drugs: FF/VI, FF/UMEC/VI
Study Phase: Phase 3
A Randomized, Double Blind, Parallel Group Study of the Efficacy and Safety of Mepolizumab as Adjunctive Therapy in Patients With Severe Asthma With Eosinophilic Inflammation
A Randomized, Double Blind, Parallel Group Study of the Efficacy and Safety of Mepolizumab as Adjunctive Therapy in Patients With Severe Asthma With Eosinophilic Inflammation
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drugs: Mepolizumab, Salbutamol
Study Phase: Phase 3
View 2 Less Clinical Trials

279 Total Publications

A Real-time Artifact Removal System for Closed-loop Deep Brain Stimulation.
A Real-time Artifact Removal System for Closed-loop Deep Brain Stimulation.
Journal: IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society
Published: August 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wu's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 62 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile